Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726372 | SCV000344136 | uncertain significance | not provided | 2016-07-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000342276 | SCV000518458 | likely benign | not specified | 2017-04-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000726372 | SCV001025557 | likely benign | not provided | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000342276 | SCV002072256 | uncertain significance | not specified | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000726372 | SCV004701426 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | LAMC3: BP4 |
Prevention |
RCV003920158 | SCV004729805 | likely benign | LAMC3-related condition | 2023-05-19 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Centre de Biologie Pathologie Génétique, |
RCV001252295 | SCV001428047 | likely benign | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing |